Lot of queries related to the classification criteria(CC) for #Sjogrens syndrome. Hence, this 🧵
The criteria are the result of a collaborative effort by researchers in the US & Europe.
PS:CC are for use in trials and not for clinical Dx #MedTwitter#rheumtwitter
👉🏽A giant leap over the previous CC – as systemic features have a place
👉🏽ESSDAI – originally developed by EULAR Sjögren’s Task Force for assessing disease activity, but also has a role in CC
👉🏽Attaching original papers - CC ncbi.nlm.nih.gov/pmc/articles/P…
While looking through case reports of #Sjogrens and renal tubular acidosis, came across a peculiar neurological demyelinating disorder...
A long 🧵 #rheumtwitter#neurotwitter#MedTwitter
Intriguingly, there were multiple reports of osmotic demyelination syndrome (ODS), aka central pontine/extrapontine myelinolysis.
#Sjogren has varied neurological features and its association with #NMOSD, a demyelinating autoimmune disorder is well-known but ODS is non-inflammatory and ...
🤔Neither Sjogren nor RTA is an established risk factor for ODS
#Sjogrens Syndrome - Year-end thoughts.
Ever since I have been a rheumatologist, I have always found diagnostic delay distressing, and perhaps nowhere is it as prevalent as in Sjogren's.
I am summarising some of my thoughts in a short-long🧵
⭕️The experiences of the very brave and inspiring patients have brought the focus back on the diagnosis of #Sjogrens